TCL Archive Iressa Authorization In Europe Clarifies Differences Between U.S., E.U. Standards By Cancer History Project July 31, 2009
TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer By Cancer History Project July 31, 2009
TCL Archive Studies Shed Light On Racial Disparities Between Blacks, Whites With Breast Cancer By Cancer History Project July 31, 2009
TCL Archive HIPAA Interpretations Vary, Delay Research, ASCO Study Finds By Cancer History Project July 31, 2009
TCL Archive Shorter, Simpler Consent Form Proposed For Phase I Trials By Cancer History Project July 31, 2009
TCL Archive How Much Is Life Worth? The $440 Billion Question By Cancer History Project July 31, 2009
Article Robert Mayer talks about the half-century of misses that preceded the development of daraxonrasib By Cancer History Project
Primary Source Backwater to Blockbuster: St. Jude Children’s Research Hospital By Cancer History Project
